National Home Infusion Association v. Azar

CourtDistrict Court, District of Columbia
DecidedJune 15, 2021
DocketCivil Action No. 2019-0393
StatusPublished

This text of National Home Infusion Association v. Azar (National Home Infusion Association v. Azar) is published on Counsel Stack Legal Research, covering District Court, District of Columbia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
National Home Infusion Association v. Azar, (D.D.C. 2021).

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

NATIONAL HOME INFUSION ASSOCIATION,

Plaintiff,

v. Civil Action No. 19-393 (TJK) XAVIER BECERRA, in his official capacity as Secretary of Health and Human Services,

Defendant.

MEMORANDUM OPINION

Plaintiff National Home Infusion Association (NHIA) is a nonprofit organization of

member companies that provide home infusion medical services, which allow some patients to

receive certain drugs at home instead of in a hospital. NHIA sues Defendant, the Secretary of

Health and Human Services, alleging that his regulation defining “drug administration calendar

day” under the relevant benefit program conflicts with the Medicare Act and violates the

Administrative Procedure Act in several ways. The Secretary has moved to dismiss, arguing that

the Court lacks subject-matter jurisdiction because NHIA’s members have not exhausted their

administrative remedies, and in the alternative, seeks summary judgment because the regulation

is otherwise lawful. For the reasons explained below, the Court will dismiss the complaint

because it lacks subject-matter jurisdiction. Background

A. Legal and Regulatory Background

The Medicare Act, 42 U.S.C. § 1395 et seq., establishes a program of health insurance for

the elderly and the disabled. Under Medicare Part B, the federal government pays for certain

outpatient infusion drugs that are “incident to” a physician’s services, as long as the drugs are not

usually self-administered by a patient. 42 U.S.C. § 1395x(s)(2)(A), (B). The Center for Medical

Services (CMS), an agency housed within the Department of Human Health and Services (HHS),

administers the Medicare program through private contractors known as Medicare

Administrative Contractors (MACs). 42 U.S.C. §§ 1395u(a), 1395kk-1(a)(4).

Congress created a new Medicare benefit for home infusion therapy services in 2016.

See 21st Century CURES Act, Pub. L. No. 114-255, § 5004, 130 Stat. 1033, 1190 (2016). That

legislation authorized CMS to promulgate a payment scheme for certain items and services

associated with home infusion therapy, effective January 1, 2021. See 42 U.S.C.

§ 1395m(u)(1)(A).

In later legislation, Congress instructed the Secretary of HHS (“the Secretary”) to

establish a temporary transitional benefit program to compensate eligible home infusion therapy

suppliers for certain designated drugs until CMS established the permanent program. See

Bipartisan Budget Act of 2018, Pub. L. No. 115-123, § 50401, 132 Stat. 64, 214 (2018). The Act

specifically ordered the Secretary to “establish a single payment amount for each such payment

category . . . for each infusion drug administration calendar day in the individual’s home for

drugs assigned to such category.” 42 U.S.C. § 1395m(u)(7)(B)(iv). The Act also clarified that

“a reference to payment to [an eligible home infusion supplier or a qualified home infusion

therapy supplier] for an infusion drug administration calendar day in the individual’s home shall

refer to payment only for the date on which professional services [as described elsewhere in the

2 statute] were furnished to administer such drugs to such individual.” 42 U.S.C.

§ 1395m(u)(7)(E)(i).

In devising the temporary transitional benefit program, the Secretary defined “infusion

drug administration calendar day” as the “day on which home infusion therapy services are

furnished by skilled professionals in the individual’s home on the day of infusion drug

administration.” 42 C.F.R. § 486.505 (“Final Rule”); 83 Fed. Reg. 56,406, 56,579–583 (Nov.

13, 2018). Under the Final Rule, whether or not a professional is “skilled” turns on whether the

services they provide are “so inherently complex that they can only be safely and effectively

performed by, or under the supervision of, professional or technical personnel.” Id.

B. Procedural Background

National Home Infusion Association (NHIA) is a not-for-profit association that

represents home infusion therapy companies. ECF No. 1 ¶ 11. Under Medicare, its members are

reimbursed for medical services they provide to patients. Id. Three of NHIA’s members—

BioScrip, Inc., Intramed Plus, and Paragon Healthcare, Inc.—presented claims to the Secretary

for Medicare reimbursement. Id. ¶ 13. BioScrip requested Medicare reimbursement from a

MAC on February 7, 2019. ECF No. 15-1 ¶ 5. On February 13, 2019, Intramed Plus also

presented claims to a MAC. Id.¶ 4. The next day, February 14, 2019, Paragon Healthcare

presented its claims to a MAC. Id. ¶ 6. All three providers’ claims sought “payment for days

where the patient was infused but a nurse or other skilled professional was not present in the

home.” ECF No. 9-2 ¶¶10–14. All three sets of claims were denied. William Noyes, Senior

Vice President of Reimbursement Policy at NHIA, submitted to the Court remittance notices

dated between February 13 and February 21, 2019, which he asserts are “representative of the

DME MAC’s claims processing decisions” of NHIA’s members’ claims. ECF No. 15-1 ¶¶ 4–6.

Most of the notices contain two codes explaining why the MAC denied the claim. See, e.g., id.

3 at 11. The first code, M25, means that “[t]he information furnished does not substantiate the

need for this level of service.” Id. The second code, N180, signifies that the provided “item or

service does not meet the criteria for the category under which it was billed.” Id. A minority of

the notices only contain the N180 code, see, e.g., id. at 12, but, like all the notices, they do not

explain why the item or service did not meet the criteria for the category under which it was

billed. NHIA filed a separate exhibit showing that of the fifty claims the three members

submitted, forty-two led to remittance notices containing both codes and eight resulted in notices

containing only the N180 code. ECF No. 9-2 at 118. NHIA represents that all three companies

sought redetermination of the denied claims and that, at the time it moved for summary

judgment, those appeals remained pending. ECF No. 15-1 ¶¶ 4–6.

NHIA filed this lawsuit on behalf of its members on February 14, 2019—within days of

all three of its members’ first request for reimbursement—alleging that the Final Rule conflicts

with § 1395m(u)(7) of the Medicare Act and otherwise violates the Administrative Procedure

Act. ECF No. 1. NHIA then moved for summary judgment, and Defendant moved to dismiss

for lack of subject-matter jurisdiction, or in the alternative, for summary judgment. ECF No. 13.

After the motions had been pending for about a year, the case was reassigned to the undersigned.

See ECF No. 24.

Legal Standards

“Federal courts are courts of limited jurisdiction.” Kokkonen v. Guardian Life Ins. Co. of

Am., 511 U.S. 375, 377 (1994).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Weinberger v. Salfi
422 U.S. 749 (Supreme Court, 1975)
Mathews v. Eldridge
424 U.S. 319 (Supreme Court, 1976)
Bowen v. City of New York
476 U.S. 467 (Supreme Court, 1986)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Kokkonen v. Guardian Life Insurance Co. of America
511 U.S. 375 (Supreme Court, 1994)
TRIAD AT JEFFERSONVILLE I, LLC v. Leavitt
563 F. Supp. 2d 1 (District of Columbia, 2008)
Colorado Heart Institute, LLC v. Johnson
609 F. Supp. 2d 30 (District of Columbia, 2009)
Hall v. Sebelius
689 F. Supp. 2d 10 (District of Columbia, 2009)
National Association for Home Care & Hospice, Inc. v. Sebelius
77 F. Supp. 3d 103 (District of Columbia, 2015)
Arturo Porzecanski v. Alex Azar
943 F.3d 472 (D.C. Circuit, 2019)
American Hospital Association v. Alex Azar, II
967 F.3d 818 (D.C. Circuit, 2020)
Am. Hosp. Ass'n v. Azar
348 F. Supp. 3d 62 (D.C. Circuit, 2018)
Am. Hosp. Ass'n v. Azar
895 F.3d 822 (D.C. Circuit, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
National Home Infusion Association v. Azar, Counsel Stack Legal Research, https://law.counselstack.com/opinion/national-home-infusion-association-v-azar-dcd-2021.